Results 61 to 70 of about 7,917 (182)

The multiple hit model of infantile and epileptic spasms: The 2025 update

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Infantile and epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy manifesting with epileptic spasms and poor neurodevelopmental outcomes. There is an urgent need for the development of more effective and tolerated therapies.
Aristea S. Galanopoulou   +6 more
wiley   +1 more source

Electroretinography (ERG) Monitoring for Vigabatrin Visual Toxicity (The Cons)

open access: yes, 2021
Vigabatrin is a known cause of ocular toxicity and visual field loss. Early reports estimated ocular toxicity at 52% in adults and 34% in children. However, most early data was from small, retrospective studies and, crucially, many patients did not have ...
Michael J. Wan
core  

UK Multicenter Randomized Trial of Hormonal Treatments Vs Vigabatrin for Infantile Spasms

open access: yesPediatric Neurology Briefs, 2010
The UK Infantile Spasms Multicenter Study previously showed that seizure control after 14 days and development at 14 months are better following hormonal treatments (prednisolone or tetracosactide depot) than following vigabatrin.
J Gordon Millichap
doaj   +1 more source

Ketogenic diet for infantile epileptic spasms

open access: yesEpilepsia Open, EarlyView.
Abstract Approximately half of all cases of Infantile Epileptic Spasms Syndrome (IESS) do not respond to vigabatrin and hormonal therapies. There is no clear consensus as to the second‐line therapy for IESS. Ketogenic diet (KD) has emerged as an effective treatment for certain drug‐resistant epilepsies and in many cases of IESS.
Morris H. Scantlebury   +3 more
wiley   +1 more source

Gas chromatographic assay of vigabatrin enantiomers in plasma

open access: yes, 1993
A rapid and specific gas chromatographic method has been developed for the determination of plasma R(-)- and S(+)-vigabatrin concentrations. The method involves a double derivatisation step, chromatography on a megabore Chirasil-Val capillary column and ...
G.E. McKinnon   +5 more
core   +1 more source

Vigabatrin Associated Retinal Pathology

open access: yesPediatric Neurology Briefs, 2002
A prospective study of 29 children treated with vigabatrin (VGB) as add on therapy for epilepsy included ophthalmic examination before and at 6-month intervals for 6.5 years, at Sultan Qaboos University Hospital, Sultanate of Oman.
J Gordon Millichap
doaj   +1 more source

Peripheral retinal dysfunction in patients taking vigabatrin

open access: yes, 2003
Objective: To assess the wide-field multifocal electroretinogram (WF-mfERG) for assessment of retinal function in vigabatrin-treated patients. Methods: Thirty-two adults who had taken vigabatrin for at least 3 years for localization-related epilepsy ...
Keating, D.   +10 more
core   +1 more source

Visual Fields in Mothers and Children Exposed in Utero to Vigabatrin

open access: yesPediatric Neurology Briefs, 2009
Three mothers with 4 children exposed to vigabatrin in utero (but not breast fed) underwent perimetry and imaging of the retinal nerve fiber layer (RNFL) at the University Hospital of Wales and School of Optometry, Cardiff, UK.
J Gordon Millichap
doaj   +1 more source

The gut microbiome and drug‐resistant epilepsy: Microbiome–antiseizure medication interactions and implications for pharmacoresistance

open access: yesEpilepsia Open, EarlyView.
Abstract Drug‐resistant epilepsy (DRE) affects approximately one‐third of patients with epilepsy and represents a major unmet clinical need. While traditional hypotheses of pharmacoresistance have focused on alterations in drug targets, efflux transporter overexpression, and intrinsic disease severity, the gut microbiome has recently emerged as a ...
Khaled Zammar   +4 more
wiley   +1 more source

Test for Vigabatrin-Induced Field Defects in Children

open access: yesPediatric Neurology Briefs, 2002
A visual-evoked potential (VEP) technique for identifying visual field defects in children with epilepsy treated with vigabatrin has been developed at Aston University, Birmingham, and Cardiff University, UK.
J Gordon Millichap
doaj   +1 more source

Home - About - Disclaimer - Privacy